Search Within

Han Xiao

Formats
  1. Meeting Abstract (32)
  2. Journal Article (26)
  3. Book Section (1)
Groups
  1. Department of Medicine (59)
  2. Genitourinary Oncology Service (59)
  3. Solid Tumor Oncology Division (59)
  4. Epidemiology and Biostatistics (21)
  5. Survivorship Research (20)
  6. Biostatistics Service (16)

More Groups

People
  1. Eric Sherman (13)
  2. David Pfister (12)
  3. Matthew Fury (11)
  4. Sofia Haque (10)
  5. Alan Ho (9)
  6. Dean Bajorin (9)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Oncology (5)
  3. Cancer (3)
  4. Head & Neck (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Atlas of Genitourinary Oncological Imaging (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Oxford University Press (6)
  3. Wiley Blackwell (3)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa)
    Meeting Abstract

    McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W.; Den, R. B.; Deville, C.; Borofsky, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Emergency department (ED) presenting symptom clusters for chemotherapy patients
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Gorenshteyn, D.; Sokolowski, S.; Gazit, L.; Adams, L.; Matays, J.; Katzen, L. L.; Chiu, O. O.; Xiao, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: An Alliance Foundation trial (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Eggener, S. E.; Chen, R. C.; Heller, G.; Patnaik, A.; Xiao, H.; Weckstein, D.; Mohler, J.; Watson, M.; Taplin, M. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Long-term quality of life in older patients with HPV-related oropharyngeal cancer
    Journal Article

    Baxi, S. S.; Cullen, G.; Xiao, H.; Atoria, C. L.; Sherman, E. J.; Ho, A.; Lee, N. Y.; Elkin, E. B.; Pfister, D. G.
    Head & Neck (2018)

    Fulltext@MSK | Save
  • Misery loves company: Presenting symptom clusters to urgent care by patients receiving antineoplastic therapy
    Journal Article

    Daly, B.; Nicholas, K.; Gorenshteyn, D.; Sokolowski, S.; Gazit, L.; Adams, L.; Matays, J.; Katzen, L. L.; Chiu, Y. O.; Xiao, H.; more...
    Journal of Oncology Practice (2018)

    Fulltext@MSK | Save
  • Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Dunn, L. A.; Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Korte, S.; Pfister, C.; Haque, S.; Katabi, N.; Ho, A. L.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Proton radiotherapy for incurable recurrent or metastatic cancers of the head and neck by the RTOG 8502 hypofractionated palliative schedule
    Meeting Abstract

    Lok, B. H.; Zong, J.; Gutinov, S. I.; Cai, X.; Deselm, C.; Romesser, P. B.; Lanning, R. M.; Shcherba, M.; Xiao, H.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save